Home / Publications / Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers

Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers

Tamara Vladimirovna Shushpanova 1, 2
Tamara Vladimirovna Shushpanova
Nikolay Aleksandrovich Bokhan 1, 3
Nikolay Aleksandrovich Bokhan
Galina B Slepchenko 4
Galina B Slepchenko
Evgeniya Valer'evna Markova 5
Evgeniya Valer'evna Markova
Olga V Shushpanova 6
Olga V Shushpanova
Irina N Smirnova 2
Irina N Smirnova
Alexei Aleksandrovich Zaitsev 2
Alexei Aleksandrovich Zaitsev
Natalia Eduardovna Kolomiets 3, 7
Natalia Eduardovna Kolomiets
Viktor Dmitrievich Filimonov 4
Viktor Dmitrievich Filimonov
1 Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation
2 Tomsk Research Institute of Balneology and Physiotherapy, Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology, Tomsk, Russian Federation
3 Siberian State Medical University, Tomsk, Russian Federation
4 National Research Tomsk Polytechnic University, Tomsk, Russian Federation
5 Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
6 Scientific Center for Mental Health, Moscow, Russian Federation
7 Kemerovo State Medical University, Kemerovo, Russia
Published 2024-10-22
CommunicationVolume 34, Issue 6, 854-858
0
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Shushpanova T. V. et al. Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers // Mendeleev Communications. 2024. Vol. 34. No. 6. pp. 854-858.
GOST all authors (up to 50) Copy
Shushpanova T. V., Bokhan N. A., Slepchenko G. B., Markova E. V., Shushpanova O. V., Smirnova I. N., Zaitsev A. A., Kolomiets N. E., Kuksenok V. Y., Filimonov V. D. Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers // Mendeleev Communications. 2024. Vol. 34. No. 6. pp. 854-858.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2024.10.027
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.10.027
TI - Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers
T2 - Mendeleev Communications
AU - Shushpanova, Tamara Vladimirovna
AU - Bokhan, Nikolay Aleksandrovich
AU - Slepchenko, Galina B
AU - Markova, Evgeniya Valer'evna
AU - Shushpanova, Olga V
AU - Smirnova, Irina N
AU - Zaitsev, Alexei Aleksandrovich
AU - Kolomiets, Natalia Eduardovna
AU - Kuksenok, Vera Yur'evna
AU - Filimonov, Viktor Dmitrievich
PY - 2024
DA - 2024/10/22
PB - Mendeleev Communications
SP - 854-858
IS - 6
VL - 34
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Shushpanova,
author = {Tamara Vladimirovna Shushpanova and Nikolay Aleksandrovich Bokhan and Galina B Slepchenko and Evgeniya Valer'evna Markova and Olga V Shushpanova and Irina N Smirnova and Alexei Aleksandrovich Zaitsev and Natalia Eduardovna Kolomiets and Vera Yur'evna Kuksenok and Viktor Dmitrievich Filimonov},
title = {Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers},
journal = {Mendeleev Communications},
year = {2024},
volume = {34},
publisher = {Mendeleev Communications},
month = {Oct},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.10.027},
number = {6},
pages = {854--858},
doi = {10.1016/j.mencom.2024.10.027}
}
MLA
Cite this
MLA Copy
Shushpanova, Tamara Vladimirovna, et al. “Halonal, an original benzoylated phenobarbital derivative anticonvulsant: in vivo evaluation, chemometric and molecular docking studies of enantiomers.” Mendeleev Communications, vol. 34, no. 6, Oct. 2024, pp. 854-858. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.10.027.

Keywords

2-fluorobenzoyl substituent.
anticonvulsant
barbiturates
enantiomer
GABAA receptor
molecular docking
γ-aminobutyric acid

Abstract

An original phenobarbital anticonvulsant Halonal, 5-ethyl-1-(2-fluorobenzoyl)-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione, stimulated the cellular immune and the humoral response in long-term alcoholized male (CBAxC57Bl/6) F1 mice to the level of healthy animals. Voltammetry was found to be suitable for determination of Halonal R/S-enantiomeric ratio, which was exemplified on the authentic sample with the R/S-composition of 40:60. Molecular docking (Schrodinger program, Glide) showed that Halonal behaved as a benzonal derivative interacting with GABAAR via the BARB binding site, with S-Halonal having higher similarity score than its R-enantiomer because of a different orientation of the 2-fluorobenzoyl substituent.

References

.
Orthosteric and benzodiazepine cavities of the α1β2γ2 GABAA receptor: insights from experimentally validated in silico methods
Amundarain M.J., Viso J.F., Zamarreño F., Giorgetti A., Costabel M.
Journal of Biomolecular Structure and Dynamics, 2018
.
Chronic alcohol consumption alters extracellular space geometry and transmitter diffusion in the brain
De Santis S., Cosa-Linan A., Garcia-Hernandez R., Dmytrenko L., Vargova L., Vorisek I., Stopponi S., Bach P., Kirsch P., Kiefer F., Ciccocioppo R., Sykova E., Moratal D., Sommer W.H., Canals S., et. al.
Science advances, 2020
.
Relative positioning of diazepam in the benzodiazepine-binding-pocket of GABAAreceptors
Tan K.R., Baur R., Charon S., Goeldner M., Sigel E.
Journal of Neurochemistry, 2009
.
Neurobiology of addiction: a neurocircuitry analysis
Koob G.F., Volkow N.D.
The Lancet Psychiatry, 2016
.
Development of a new permeability assay using low‐efflux MDCKII cells
Di L., Whitney‐Pickett C., Umland J.P., Zhang H., Zhang X., Gebhard D.F., Lai Y., Federico J.J., Davidson R.E., Smith R., Reyner E.L., Lee C., Feng B., Rotter C., Varma M.V., et. al.
Journal of Pharmaceutical Sciences, 2011
.
Extra Precision Glide:  Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren T.A., Sanschagrin P.C., Mainz D.T.
Journal of Medicinal Chemistry, 2006
.
Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
Halgren T.A., Murphy R.B., Friesner R.A., Beard H.S., Frye L.L., Pollard W.T., Banks J.L.
Journal of Medicinal Chemistry, 2004
.
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
Madhavi Sastry G., Adzhigirey M., Day T., Annabhimoju R., Sherman W.
Journal of Computer-Aided Molecular Design, 2013
.
An Innovatory GABA Receptor Modulator and Liver Oxidase System Microsomal Cytochrome P450 Activator in Patients with Alcoholism
Shushpanova T.V., Bokhan N.A., Stankevich K.S., Novozheeva T.P., Mandel’ A.I., Schastnyi E.D., Kisel’ N.I., Shushpanova O.V., Udut V.V., Safronov S.M., Boev R.S., Knyazeva E.M.
Pharmaceutical Chemistry Journal, 2021
.
Crystal structure of a human GABAA receptor
Miller P.S., Aricescu A.R.
Nature, 2014
.
An intersubunit electrostatic interaction in the GABAA receptor facilitates its responses to benzodiazepines
Pflanz N.C., Daszkowski A.W., Cornelison G.L., Trudell J.R., Mihic S.J.
Journal of Biological Chemistry, 2018
.
GABAA receptor family: overview on structural characterization
Amundarain M.J., Ribeiro R.P., Costabel M.D., Giorgetti A.
Future Medicinal Chemistry, 2019